Pathophysiology of Acute Myeloid Leukemia.
Wachter F, Pikman Y.
Acta Haematol. 2024;147(2):229-246. doi: 10.1159/000536152. Epub 2024 Feb 16.
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia.
Beneyto-Calabuig S, Merbach AK, Kniffka JA, Antes M, Szu-Tu C, Rohde C, Waclawiczek A, Stelmach P, Gräßle S, Pervan P, Janssen M, Landry JJM, Benes V, Jauch A, Brough M, Bauer M, Besenbeck B, Felden J, Bäumer S, Hundemer M, Sauer T, Pabst C, Wickenhauser C, Angenendt L, Schliemann C, Trumpp A, Haas S, Scherer M, Raffel S, Müller-Tidow C, Velten L.
Cell Stem Cell. 2023 May 4;30(5):706-721.e8. doi: 10.1016/j.stem.2023.04.001. Epub 2023 Apr 24.
Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
Cheng WY, Li JF, Zhu YM, Lin XJ, Wen LJ, Zhang F, Zhang YL, Zhao M, Fang H, Wang SY, Lin XJ, Qiao N, Yin W, Zhang JN, Dai YT, Jiang L, Sun XJ, Xu Y, Zhang TT, Chen SN, Zhu HH, Chen Z, Jin J, Wu DP, Shen Y, Chen SJ.
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2211429119. doi: 10.1073/pnas.2211429119. Epub 2022 Nov 28.
The cell of origin and the leukemia stem cell in acute myeloid leukemia.
Chopra M, Bohlander SK.
Genes Chromosomes Cancer. 2019 Dec;58(12):850-858. doi: 10.1002/gcc.22805. Epub 2019 Aug 31.
Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
Wang E, Zhou H, Nadorp B, Cayanan G, Chen X, Yeaton AH, Nomikou S, Witkowski MT, Narang S, Kloetgen A, Thandapani P, Ravn-Boess N, Tsirigos A, Aifantis I.
Cell Stem Cell. 2021 Apr 1;28(4):718-731.e6. doi: 10.1016/j.stem.2020.12.005. Epub 2021 Jan 14.
Advances in acute myeloid leukemia differentiation therapy: A critical review.
Abdel-Aziz AK.
Biochem Pharmacol. 2023 Sep;215:115709. doi: 10.1016/j.bcp.2023.115709. Epub 2023 Jul 26.
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.
San José-Enériz E, Gimenez-Camino N, Rabal O, Garate L, Miranda E, Gómez-Echarte N, García F, Charalampopoulou S, Sáez E, Vilas-Zornoza A, San Martín-Uriz P, Valcárcel LV, Barrena N, Alignani D, Tamariz-Amador LE, Pérez-Ruiz A, Hilscher S, Schutkowski M, Alfonso-Pierola A, Martinez-Calle N, Larrayoz MJ, Paiva B, Calasanz MJ, Muñoz J, Isasa M, Martin-Subero JI, Pineda-Lucena A, Oyarzabal J, Agirre X, Prósper F.
Nat Commun. 2024 Jul 2;15(1):5570. doi: 10.1038/s41467-024-49784-y.
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D, Dick JE.
Nat Med. 1997 Jul;3(7):730-7. doi: 10.1038/nm0797-730.
Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.
Ngo S, Oxley EP, Ghisi M, Garwood MM, McKenzie MD, Mitchell HL, Kanellakis P, Susanto O, Hickey MJ, Perkins AC, Kile BT, Dickins RA.
Nat Commun. 2021 Nov 11;12(1):6546. doi: 10.1038/s41467-021-26849-w.
miRNAs in acute myeloid leukemia.
Liao Q, Wang B, Li X, Jiang G.
Oncotarget. 2017 Jan 10;8(2):3666-3682. doi: 10.18632/oncotarget.12343.
